Hiroki Takashima
Kashiwa, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Attenuated Toxicity and Antitoxic Mechanism via Sodium Iodide Symporter Inhibition-Based Tumor-Selective Delivery in Astatine-211 Radioimmunotherapy.
Journal: Molecular pharmaceutics
Published: March 01, 2026
Special Issue: Evaluation of the Antitumor Mechanism of Armed Antibodies.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 07, 2023
Tumor Targeting of 211At-Labeled Antibody under Sodium Ascorbate Protection against Radiolysis.
Journal: Molecular pharmaceutics
Published: December 27, 2022
Identification of CD73 as the Antigen of an Antigen-Unknown Monoclonal Antibody Established by Exosome Immunization, and Its Antibody-Drug Conjugate Exerts an Antitumor Effect on Glioblastoma Cell Lines.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 20, 2022
Radioimmunotherapy with an 211 At-labeled anti-tissue factor antibody protected by sodium ascorbate.
Radioimmunotherapy with an 211 At-labeled anti-tissue factor antibody protected by sodium ascorbate.
Journal: Cancer science
Published: October 23, 2020
Antitumor effect of humanized anti‑tissue factor antibody‑drug conjugate in a model of peritoneal disseminated pancreatic cancer.
Journal: Oncology reports
Published: June 30, 2020
Reinforcement of antitumor effect of micelles containing anticancer drugs by binding of an anti-tissue factor antibody without direct cytocidal effects.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: January 13, 2020
Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody.
Journal: World journal of gastroenterology
Published: October 02, 2018
Last Updated: 09/26/2026